PUBLISHER: The Business Research Company | PRODUCT CODE: 1942478
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942478
Brachytherapy devices are specialized tools used to deliver internal radiation directly to or near cancerous tumors. They allow high-dose radiation treatment with minimal damage to surrounding healthy tissue, making them highly effective for cancers that are difficult to treat with external radiation.
The key product types of brachytherapy devices include brachytherapy afterloaders, brachytherapy applicators, and others. Brachytherapy afterloaders are automated systems designed to insert and withdraw radioactive sources during brachytherapy procedures, ensuring accurate dose delivery. The major indications include prostate cancer, breast cancer, cervical cancer, skin cancer, and others, with dose rates such as high-dose-rate (HDR), low-dose-rate (LDR), and pulse-dose-rate (PDR) brachytherapy. These devices are used by end users including hospitals, specialty clinics, and others.
Tariffs are impacting the brachytherapy devices market by increasing the cost of imported afterloaders, applicators, and radiation sources. Segments such as remote afterloaders and high-precision applicators are most impacted, with regions like Asia-Pacific and Europe experiencing elevated import duties. This has led to higher production costs and delays in device availability. On the positive side, tariffs encourage local manufacturing, innovation in cost-effective device production, and development of domestic supply chains.
The brachytherapy devices market research report is one of a series of new reports from The Business Research Company that provides brachytherapy devices market statistics, including brachytherapy devices industry global market size, regional shares, competitors with a brachytherapy devices market share, detailed brachytherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the brachytherapy devices industry. This brachytherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The brachytherapy devices market size has grown strongly in recent years. It will grow from $0.8 billion in 2025 to $0.85 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to limited availability of brachytherapy devices, reliance on low dose rate (ldr) treatments, increasing incidence of prostate and cervical cancers, slow adoption of automated afterloaders, constrained oncology infrastructure in emerging regions.
The brachytherapy devices market size is expected to see strong growth in the next few years. It will grow to $1.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to technological advancements in hdr and pdr brachytherapy, growth of specialty cancer clinics, rising investment in oncology healthcare, integration of ai and digital planning software, expanding awareness of brachytherapy benefits among clinicians. Major trends in the forecast period include rising adoption of high dose rate (hdr) brachytherapy, increasing use of minimally invasive brachytherapy procedures, expansion of cancer treatment centers and specialty clinics, integration of treatment planning software and qa devices, growing focus on patient safety and precision radiation delivery.
The increasing prevalence of cancer is expected to propel the growth of the brachytherapy devices market going forward. Cancer is a complex group of diseases characterized by uncontrolled cell growth and the potential to spread to other parts of the body. The rising prevalence of cancer is attributed to factors such as population aging, lifestyle changes, genetic predispositions, and environmental exposures. Brachytherapy devices provide substantial benefits to cancer patients by delivering targeted radiation directly to tumors, maximizing treatment effectiveness while minimizing damage to surrounding healthy tissue. This targeted approach enhances therapeutic efficacy, reduces side effects, shortens treatment duration, and lowers the risk of cancer recurrence, ultimately improving patient outcomes and quality of life. For instance, in August 2024, according to Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK were living with cancer in 2024, with projections indicating an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of the brachytherapy devices market.
Leading companies operating in the brachytherapy devices market are focusing on developing innovative solutions, such as advanced brachytherapy machines, to support patients requiring specialized cancer care. Advanced brachytherapy machines are designed to deliver internal radiation therapy with high precision, safety, and effectiveness by targeting cancerous tissue while minimizing exposure to surrounding healthy structures. For example, in June 2024, AIIMS Nagpur, an India-based medical institute, launched a state-of-the-art brachytherapy machine to improve the accuracy of cancer treatment. This technology enables localized radiation delivery, enhances treatment outcomes, and reduces damage to healthy tissue by providing controlled and precise radiation therapy.
In October 2023, Elekta, a Sweden-based neuroscience company, acquired the Xoft business from iCAD Inc. for an undisclosed amount. With this acquisition, Elekta aims to strengthen its brachytherapy portfolio and provide improved treatment outcomes for cancer patients. iCAD Inc. is a US-based manufacturer of brachytherapy devices.
Major companies operating in the brachytherapy devices market are Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Koninklijke Philips N.V., Varian Medical Systems Inc., Carl Zeiss Meditec AG, Elekta AB, Hologic Inc., Mirion Technologies Inc., Accuray Inc., Eckert & Ziegler BEBIG S.A., Theragenics Corporation, Sensus Healthcare Inc., Aetna Inc., CIVCO Medical Solutions, iCAD Inc., IsoRay Inc., BEBIG Medical GmbH, IsoAid L.L.C.
North America was the largest region in the brachytherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the brachytherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the brachytherapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The brachytherapy devices market consists of sales of applicators, catheters, needles, and seed implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Brachytherapy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses brachytherapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for brachytherapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brachytherapy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.